CHMP recommends Sanofi's Xenpozyme for rare disease ASMD

Positive opinion is based on data from clinical trials which showed improvement in lung function - News - PharmaTimes

Related Keywords

Japan ,Sanofi Xenpozyme ,Drug Administration ,European Medicines Agency ,Medicinal Products ,Human Use ,Breakthrough Therapy ,Biologics License Application ,Chmp ,Sanofi ,Xenpozyme ,